...
首页> 外文期刊>CardioVascular and Interventional Radiology >Extracranial Carotid Artery Stenting in Surgically High-Risk Patients Using the Carotid Wallstent Endoprosthesis: Midterm Clinical and Ultrasound Follow-Up Results
【24h】

Extracranial Carotid Artery Stenting in Surgically High-Risk Patients Using the Carotid Wallstent Endoprosthesis: Midterm Clinical and Ultrasound Follow-Up Results

机译:使用颈动脉壁内支架术的高危外科患者的颅外颈动脉支架置入术:中期临床和超声随访结果

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of this study was to evaluate the feasibility, safety and midterm outcome of elective implantation of the Carotid Wallstent® in patients considered to be at high surgical risk. In a prospective study, 54 carotid artery stenoses in 51 patients were stented over a 24-month period. Three patients underwent bilateral carotid artery stenting. Institutional inclusion criteria for invasive treatment of carotid occlusive disease (carotid endarterectomy or carotid artery stenting) are patients presenting with a 70% or more symptomatic stenosis and those with an 80% or more asymptomatic stenosis having a life-expectancy of more than 1 year. All patients treated by carotid artery stenting were considered at high risk for carotid endarterectomy because of a hostile neck (17 patients—31.5%) or because of severe comorbidities (37 patients—68.5%). No cerebral protection device was used. Of the 54 lesions, 33 (61.1%) were symptomatic and 21 (38.8%) were asymptomatic. Follow-up was performed by physical examination and by duplex ultrasonography at 1 month, 6 months, 1 year and 2 years after the procedure. All 54 lesions could be stented successfully without periprocedural stroke. Advert events during follow-up (mean 13.9 ± 5.7 months) were non-stroke-related death in 6 patients (11.1%), minor stroke in 4 stented hemispheres (7.4%), transient ipsilateral facial pain in 1 patient (1.8%), infection of the stented surgical patch in 1 patient (1.8%) and asymptomatic instent restenosis in 4 patients (7.4%). The percutaneous implantation of the Carotid Wallstent®, even without cerebral protection device, appears to be a safe procedure with acceptable clinical and ultrasonographic follow-up results in patients at high surgical risk. But some late adverse events such as ipsilateral recurrence of non-disabling (minor) stroke or instent restenosis still remain real challenging problems.
机译:这项研究的目的是评估在被认为具有高手术风险的患者中选择性植入颈动脉Wallstent®的可行性,安全性和中期结果。在一项前瞻性研究中,在24个月内将51例患者的54个颈动脉狭窄置入支架。三例患者接受了双侧颈动脉支架置入术。侵入性治疗颈动脉闭塞性疾病(颈动脉内膜切除术或颈动脉支架置入术)的机构入选标准是出现70%或以上症状性狭窄的患者和80%或以上无症状性狭窄且预期寿命超过1年的患者。所有因颈动脉敌对(17例,占31.5%)或严重合并症(37例,占68.5%),均经颈动脉支架置入术治疗的患者被认为处于高风险。没有使用脑保护装置。在54个病灶中,有症状的占33个(61.1%),无症状的占21个(38.8%)。术后1个月,6个月,1年和2年通过体格检查和双工超声检查进行随访。所有54个病变均可以成功植入支架,而无围手术期卒中。随访期间(平均13.9±5.7个月)的广告事件为6例患者(11.1%)与中风无关的死亡,4例支架半球轻度卒中(7.4%),1例患者的同侧短暂性面部疼痛(1.8%) ,1例患者(1.8%)的支架外科修补感染,4例患者(7.4%)的无症状性再狭窄。即使没有脑保护装置,经皮植入CarotidWallstent®似乎也是一种安全的方法,对于高手术风险的患者,可以接受可接受的临床和超声检查结果。但是,一些晚期不良事件,如非致残性(轻度)中风的同侧复发或再狭窄仍是真正具有挑战性的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号